{"doi":"10.1038/s41541-024-00899-9","title":"Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice","abstract":"<jats:title>Abstract</jats:title>\n                  <jats:p>Live-Attenuated Vaccines (LAVs) stimulate robust mucosal and cellular responses and have the potential to protect against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV), the main etiologic agents of viral bronchiolitis and pneumonia in children. We inserted the RSV-F gene into an HMPV-based LAV (Metavac®) we previously validated for the protection of mice against HMPV challenge, and rescued a replicative recombinant virus (Metavac®-RSV), exposing both RSV- and HMPV-F proteins at the virion surface and expressing them in reconstructed human airway epithelium models. When administered to BALB/c mice by the intranasal route, bivalent Metavac®-RSV demonstrated its capacity to replicate with reduced lung inflammatory score and to protect against both RSV and lethal HMPV challenges in vaccinated mice while inducing strong IgG and broad RSV and HMPV neutralizing antibody responses. Altogether, our results showed the versatility of the Metavac® platform and suggested that Metavac®-RSV is a promising mucosal bivalent LAV candidate to prevent pneumovirus-induced diseases.</jats:p>","journal":"npj Vaccines","year":2024,"id":647138,"datarank":0.48283137373023016,"base_score":3.2188758248682006,"endowment":3.2188758248682006,"self_citation_contribution":0.48283137373023016,"citation_network_contribution":0.0,"self_endowment_contribution":0.48283137373023016,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":24,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1685833,"name":"Pauline Brun","orcid":"0000-0003-0762-832X","position":1,"is_corresponding":false},{"id":1685834,"name":"Clémence Vacher","orcid":null,"position":2,"is_corresponding":false},{"id":1685835,"name":"Caroline Chupin","orcid":"0000-0003-3860-3475","position":3,"is_corresponding":false},{"id":1685836,"name":"Clément Droillard","orcid":null,"position":4,"is_corresponding":false},{"id":938116,"name":"Julie Carbonneau","orcid":"0000-0003-2697-9731","position":5,"is_corresponding":false},{"id":846452,"name":"Emilie Laurent","orcid":"0000-0002-8993-8905","position":6,"is_corresponding":false},{"id":630988,"name":"Victoria Dulière","orcid":"0000-0003-2153-0927","position":7,"is_corresponding":false},{"id":1685837,"name":"Aurélien Traversier","orcid":null,"position":8,"is_corresponding":false},{"id":553956,"name":"Olivier Terrier","orcid":"0000-0001-9393-7684","position":9,"is_corresponding":false},{"id":630989,"name":"Thomas Julien","orcid":"0000-0002-8607-2827","position":10,"is_corresponding":false},{"id":1511038,"name":"Marie Galloux","orcid":"0000-0001-7477-8489","position":11,"is_corresponding":false},{"id":481115,"name":"Stéphane Paul","orcid":"0000-0002-8830-4273","position":12,"is_corresponding":false},{"id":1511039,"name":"Jean-François Eléouët","orcid":null,"position":13,"is_corresponding":false},{"id":1685838,"name":"Julien Fouret","orcid":null,"position":14,"is_corresponding":false},{"id":1685839,"name":"Marie-Eve Hamelin","orcid":null,"position":15,"is_corresponding":false},{"id":553952,"name":"Andrés Pizzorno","orcid":"0000-0002-0918-6804","position":16,"is_corresponding":false},{"id":132248,"name":"Guy Boivin","orcid":null,"position":17,"is_corresponding":false},{"id":1685840,"name":"Manuel Rosa-Calatrava","orcid":null,"position":18,"is_corresponding":false},{"id":1685841,"name":"Julia Dubois","orcid":"0000-0002-9777-2968","position":19,"is_corresponding":false},{"id":1685832,"name":"Daniela Ogonczyk-Makowska","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice","abstract":"<jats:title>Abstract</jats:title>\n                  <jats:p>Live-Attenuated Vaccines (LAVs) stimulate robust mucosal and cellular responses and have the potential to protect against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV), the main etiologic agents of viral bronchiolitis and pneumonia in children. We inserted the RSV-F gene into an HMPV-based LAV (Metavac®) we previously validated for the protection of mice against HMPV challenge, and rescued a replicative recombinant virus (Metavac®-RSV), exposing both RSV- and HMPV-F proteins at the virion surface and expressing them in reconstructed human airway epithelium models. When administered to BALB/c mice by the intranasal route, bivalent Metavac®-RSV demonstrated its capacity to replicate with reduced lung inflammatory score and to protect against both RSV and lethal HMPV challenges in vaccinated mice while inducing strong IgG and broad RSV and HMPV neutralizing antibody responses. Altogether, our results showed the versatility of the Metavac® platform and suggested that Metavac®-RSV is a promising mucosal bivalent LAV candidate to prevent pneumovirus-induced diseases.</jats:p>","is_dataset_classified":null,"base_score":3.2188758248682006,"endowment":3.2188758248682006,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38898106","pmcid":"PMC11187144","openalex_id":"https://openalex.org/W4399799471","authors":[],"funders":[{"funder_name":"Association Nationale de la Recherche et de la Technologie","grant_id":"2020 0656","title":null},{"funder_name":"Gouvernement du Canada | Canadian Institutes of Health Research","grant_id":"148361","title":null},{"funder_name":"Agence Nationale de la Recherche","grant_id":"AAP19 Metavac-T17","title":null},{"funder_name":"Canadian Institutes of Health Research","grant_id":"unidentified","title":"unidentified"}],"total_grants":4,"fwci":6.7458,"citation_percentile":0.97665482,"influential_citations":0,"citation_trend":[{"year":2025,"count":16},{"year":2026,"count":8}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.nature.com/articles/s41541-024-00899-9.pdf","host_type":"journal"},{"url":"https://www.nature.com/articles/s41541-024-00899-9.pdf","host_type":"publisher"},{"url":"https://www.nature.com/articles/s41541-024-00899-9","host_type":"publisher"},{"url":"https://doi.org/10.1038/s41541-024-00899-9","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38898106","host_type":"repository"},{"url":"https://hal.inrae.fr/hal-04633271","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11187144","host_type":"repository"},{"url":"https://doaj.org/article/35720c421bc04cb3b367e50f8e351eb9","host_type":"repository"},{"url":"http://hdl.handle.net/20.500.12210/130101","host_type":"repository"},{"url":"https://hal.inrae.fr/hal-04633271/document","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11187144/pdf/41541_2024_Article_899.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC11187144","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC11187144?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1038/s41541-024-00899-9","host_type":""},{"url":"https://hal.inrae.fr/hal-04633271v1/document","host_type":""},{"url":"https://hal.inrae.fr/hal-04633271v1","host_type":""},{"url":"https://doi.org/https://doi.org/10.1038/s41541-024-00899-9","host_type":""}],"fields_of_study":["Respiratory viral infections research","Viral gastroenteritis research and epidemiology","Pneumonia and Respiratory Infections","0301 basic medicine","0303 health sciences","03 medical and health sciences"],"mesh_terms":[],"keywords":["Human metapneumovirus","Virology","Bronchiolitis","Metapneumovirus","Bivalent (engine)","Virus","Biology","Nasal administration","Human Parainfluenza Virus","Paramyxoviridae","Respiratory system","Immunology","Respiratory tract infections","Viral disease","Chemistry","[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology","610","Neoplasms. Tumors. Oncology. Including cancer and carcinogens","600","RC581-607","Article","[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology","[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology","[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology","Immunologic diseases. Allergy","RC254-282"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"gen"},{"name":"doi"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T17:01:59.595471Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}